Literature DB >> 16028158

Human metapneumovirus infection in adults with community-acquired pneumonia and exacerbation of chronic obstructive pulmonary disease.

M E Hamelin1, S Côté, J Laforge, N Lampron, J Bourbeau, K Weiss, R Gilca, G DeSerres, G Boivin.   

Abstract

We tested nasopharyngeal aspirate specimens by real-time polymerase chain reaction assays and paired serum samples by enzyme-linked immunosorbent assays. Acute human metapneumovirus infections were identified in 6 (4.1%) of 145 adult patients who presented to the emergency department for pneumonia or acute exacerbation of chronic obstructive pulmonary disease during 2 winter/spring seasons in Quebec, Canada.

Entities:  

Mesh：

Year:  2005        PMID： 16028158     DOI： 10.1086/431981

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  51 in total

Review 1.  The influence of virus infections on the course of COPD.

Authors:  H Frickmann; S Jungblut; T O Hirche; U Groß; M Kuhns; A E Zautner
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2012-09-10

2.  Effect of ribavirin and glucocorticoid treatment in a mouse model of human metapneumovirus infection.

Authors:  Marie-Eve Hamelin; Gregory A Prince; Guy Boivin
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

3.  Evaluation of a commercial direct fluorescent-antibody assay for human metapneumovirus in respiratory specimens.

Authors:  Donald C Vinh; Diane Newby; Hugues Charest; Jane McDonald
Journal:  J Clin Microbiol       Date:  2008-03-26       Impact factor: 5.948

4.  Studies of culture conditions and environmental stability of human metapneumovirus.

Authors:  Sharon J Tollefson; Reagan G Cox; John V Williams
Journal:  Virus Res       Date:  2010-04-07       Impact factor: 3.303

5.  Human metapneumovirus G protein is highly conserved within but not between genetic lineages.

Authors:  Chin-Fen Yang; Chiaoyin K Wang; Sharon J Tollefson; Linda D Lintao; Alexis Liem; Marla Chu; John V Williams
Journal:  Arch Virol       Date:  2013-02-06       Impact factor: 2.574

6.  Age-associated aggravation of clinical disease after primary metapneumovirus infection of BALB/c mice.

Authors:  M Darniot; C Pitoiset; T Petrella; S Aho; P Pothier; C Manoha
Journal:  J Virol       Date:  2009-01-14       Impact factor: 5.103

7.  The role of human metapneumovirus in the critically ill adult patient.

Authors:  Jennifer Hasvold; Michael Sjoding; Kyle Pohl; Colin Cooke; Robert C Hyzy
Journal:  J Crit Care       Date:  2015-10-23       Impact factor: 3.425

8.  Viral pathogens in acute exacerbations of chronic obstructive pulmonary disease.

Authors:  Carlos A Camargo; Adit A Ginde; Sunday Clark; Charles P Cartwright; Ann R Falsey; Dennis E Niewoehner
Journal:  Intern Emerg Med       Date:  2008-09-30       Impact factor: 3.397

9.  Population-based incidence of human metapneumovirus infection among hospitalized children.

Authors:  John V Williams; Kathryn M Edwards; Geoffrey A Weinberg; Marie R Griffin; Caroline B Hall; Yuwei Zhu; Peter G Szilagyi; Chiaoyin K Wang; Chin-Fen Yang; David Silva; Dan Ye; Richard R Spaete; James E Crowe
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

Review 10.  Role of macrolide therapy in chronic obstructive pulmonary disease.

Authors:  Fernando J Martinez; Jeffrey L Curtis; Richard Albert
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.